Online citations, reference lists, and bibliographies.
← Back to Search

Emollients, Moisturizers, And Keratolytic Agents In Psoriasis.

J. Fluhr, C. Cavallotti, E. Berardesca
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Emollients, moisturizers, and keratolytic agents are essential in the topical treatment of psoriasis. They are adjuvants for classic treatments and help to reduce the scale load of individual patients. The major role for emollients and moisturizers is the supportive role in normalizing hyperproliferation, differentiation, and apoptosis; furthermore, they exert anti-inflammatory effects, for example, through physiologic lipids. Subsequently, an improved barrier function and stratum corneum hydration makes the epidermis more resistant to external stressors and reduces the induction of Koebner phenomena. Most of the emollients are lipid-rich (sometimes oily). The keratolytic agents, especially salicylic acid, and higher concentration of urea should be used in the initial keratolytic phase, whereas moisturizing products and emollients are especially suitable in the intermediate phase and the chronic/remission phase of psoriasis. They should be combined with bath oils.
This paper references
[Keratoplastic effect of salicyclic acid, sulfur and a tensio-active mixture].
M. Gloor (1984)
[Anthralin-salicylic acid therapy of psoriasis. Cignolin-salicylic acid-vaseline treatment and Lasan paste in a right-left comparison].
U. Runne (1974)
[Recovery rate of externally administered glucocorticoids on the skin surface].
W. Wohlrab (1986)
10.1111/j.1365-2133.1976.tb04370.x
The inhibiting effect of soft paraffin on the Köbner response in psoriasis
J. Comaish (1976)
[Chronic percutaneous salicylic acid poisoning].
C. Luderschmidt (1975)
10.1111/j.1365-2133.1989.tb01335.x
Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis
Catherine E.Dewsbury (1989)
10.1007/978-3-642-83754-8_1
Review Harnstoff in der Dermatologie II
K. Müller (1989)
10.1056/NEJM199503023320907
Treatment of psoriasis.
M. Greaves (1995)
10.1111/j.1365-2133.1987.tb04123.x
In vivo measurement of the keratolytic effect of salicylic acid in three ointment formulations
T. Nook (1987)
10.1159/000252139
The interaction of anthralin, salicylic acid and zinc oxide in pastes.
H. Hulsebosch (1972)
10.1016/S0377-1237(08)80108-6
Fitzpatrick's Dermatology in General Medicine
S. Grover (2008)
10.1046/j.1468-3083.2000.00006.x
Double‐blind clinical study reveals synergistic action between alpha‐hydroxy acid and betamethasone lotions towards topical treatment of scalp psoriasis
K. Kostarelos (2000)
10.1093/OXFORDJOURNALS.QJMED.A068363
Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations.
B. J. Chapman (1989)
10.1007/BF00373431
Stratum corneum dynamic function measurements after moisturizer or irritant application
P. Treffel (2004)
The effects of a topical application of urea cream on the function of pathological stratum corneum
Y. Sasaki (1989)
Influence of emulsions with and without urea on water-binding capacity of the stratum corneum
J. Bettinger (1995)
10.1111/j.1365-2230.2005.01773.x
Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients
J. Rim (2005)
10.1111/j.1365-2133.1993.tb03338.x
Highly purified omega‐3‐polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double‐blind, placebo‐controlled multicentre study
H.‐H. HENNEICKE‐VON ZEPELIN (1993)
10.2340/0001555576353356
Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.
I. Hagemann (1996)
10.1007/s001050050479
Lebensbedrohliche Salicylatintoxikation durch perkutane Resorption bei einer schweren Ichthyosis vulgaris
R. Germann (1996)
10.1007/BF02000997
Untersuchungen über die Pharmakologie und Pharmakodynamik von Salben und salbeninkorporierten Medikamenten
C. Moncorps (2005)
10.3109/09546639709160944
Emollients as adjuvant therapy for psoriasis
A. Finlay (1997)
The influence of urea on the penetration kinetics of topically applied corticosteroids.
W. Wohlrab (1984)
10.1046/j.1467-2494.2000.00001.x
Dry skin, moisturization and corneodesmolysis
Harding (2000)
10.1007/BF02505052
Urea-containing moisturizers influence barrier properties of normal skin
M. Lodén (2006)
10.1111/j.1365-2133.1976.tb00825.x
Studies on the effect of salicylic acid on normal skin
M. Davies (1976)
10.1080/00015550510027757
Novel quantitative immunofluorescent technique reveals improvements in epidermal cell populations after mild treatment of psoriasis.
M. van Duijnhoven (2005)
[Promoting penetration of locally applied substances by urea].
G. Stüttgen (1989)
10.1159/000093984
‘Keratolytic’ Properties of Benzoyl Peroxide and Retinoic Acid Resemble Salicylic Acid in Man
J. Waller (2006)
10.1111/j.1365-2710.2007.00803.x
Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid
A. Klimowicz (2007)
10.1159/000018063
Percutaneous Absorption of Salicylic Acid in Man after Topical Administration of Three Different Formulations
F. Schwarb (1999)
[Skin resorption of salicylic acid in psoriasis patients and persons with healthy skin].
W. Arnold (1979)
Klinische Wirkung von Salicylsäure und hochdosiertem Harnstoff bei Applikation in standardisierten Magistralrezepturen aus dem Neuen Rezeptur Formularium (NRF)
M. Gloor (2001)
10.1001/ARCHDERM.1964.01600060080013
PERCUTANEOUS SALICYLIC ACID INTOXICATION IN PSORIASIS.
J. F. Vonweiss (1964)
10.1111/j.1365-2133.1980.tb06590.x
Detection of the action of salicylic acid on the normal stratum corneum
D. L. Roberts (1980)
The use of therapeutic moisturizers in various dermatologic disorders.
J. Bikowski (2001)
10.4065/76.9.943
Topical therapies for localized psoriasis.
P. Witman (2001)
10.1007/BF00741846
“Keratolytic” effect of salicylic acid
C. Huber (2004)
10.1111/j.1600-0536.1997.tb00213.x
Barrier recovery and influence of irritant stimuli in skin treated with a moisturizing cream
M. Lodén (1997)
10.1007/BF02000996
Untersuchungen über die Pharmakologie und Pharmakodynamik von Salben und salbeninkorporierten Medikamenten
C. Moncorps (2005)
10.1159/000069029
The Topical Treatment of Psoriasis
P. V. D. van de Kerkhof (2003)
10.1111/j.1365-2133.1986.tb02111.x
Short and long‐term risks of topical drugs
A. Zesch (1986)
10.1007/978-3-642-83754-8
Harnstoff in der Dermatologie
W. Raab (1989)
10.1111/j.1365-2230.1986.tb00457.x
Salicyclic acid gel for scalp psoriasis
S. Going (1986)
10.1111/j.1365-2230.1992.tb00194.x
Topical fish oil in psoriasis—a controlled and blind study
S. Escobar (1992)
10.1001/ARCHDERM.1975.01630180068008
Percutaneous absorption of salicylic acid.
J. R. Taylor (1975)
10.1007/978-3-642-83754-8_13
Salizylsäure und Harnstoff — mögliche Beeinflussung der keratolytischen Wirkung von Salizylsäure durch Harnstoff
B. Gabard (1989)
10.1007/BF00581674
Untersuchungen zum mechanismus der harnstoffwirkung auf die haut
W. Wohlrab (2004)
Moisturizers: what they are and how they work.
L. Cw (2001)
The use of emollients as sophisticated therapy in dermatology.
Ivana Nola (2003)
10.1016/J.IJPHARM.2004.11.032
Cutaneous bioassay of salicylic acid as a keratolytic.
S. Bashir (2005)
10.1080/000155599750011705
Effect of long-term use of moisturizer on skin hydration, barrier function and susceptibility to irritants.
E. Held (1999)
10.1046/J.1365-2230.1998.00361.X
Effects of glycolic acid on psoriasis.
B. Erardesca (1998)
10.1111/j.1600-0846.2004.00058.x
Use of an intraluminal guide wire in linear microdialysis probes: effect on recovery?
A. Klimowicz (2004)
Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB.
E. Fetil (2002)
On the influence of bath oils with different solvent characteristics and different amounts of a non-ionic tenside on the hydration and barrier function of the stratum corneum
J. Fluhr (1998)
[The effect of salicylic acid on epidermal cell proliferation kinetics in psoriasis. Autoradiographic in vitro-investigations(author's transl)].
H. Pullmann (1975)
10.1046/j.1365-4362.1999.00500.x
The role of salicylic acid in the treatment of psoriasis
M. Lebwohl (1999)
[Modulation of drug penetration in the skin].
J. Kalbitz (1996)
10.1016/B978-0-12-024924-4.50012-2
Lipids in normal and pathological desquamation.
M. Williams (1991)
Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis.
K. Watsky (1992)
[Clinical effect of salicylic acid and high dose urea applied according to the standardized New German Formulary].
M. Gloor (2001)
10.1046/J.1365-4362.2000.00986-3.X
Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole
A. Shemer (2000)
10.1159/000250902
Effect of topical salicylic acid on animal epidermopoiesis.
E. Weirich (1978)
[The influence of ceratolytics and moisturizers on the bio-availability of triamcinolone acetonide following topical application (author's transl)].
M. Gloor (1980)
[Salicylic acid and urea--possible modification of the keratolytic effect of salicylic acid by urea].
B. Gabard (1989)
[Effect of urea on the water binding capacity of the human stratum corneum].
W. Wohlrab (1988)
[Urea in dermatology I].
K. Müller (1989)
ORAL AND TOPICAL SUPPLEMENTATION OF LINOLEIC ACID AND SKIN DISEASE
E. Berardesca (1998)
10.1517/14728222.10.6.817
The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder
S. Philipp (2006)
Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis.
J. Péč (1992)
O/W emulsions compromise the stratum corneum barrier and improve drug penetration.
M. Gloor (2003)
10.1007/s001050050281
Stellenwert der adjuvanten Basistherapie bei chronisch-rezidivierenden Hauterkrankungen Neurodermitis atopica/Psoriasis vulgaris
E. Schöpf (1995)
10.1111/j.1600-0781.2005.00157.x
Evaluation of vaseline oil applied prior to UVB TL01 phototherapy in the treatment of psoriasis
K. Penven (2005)
10.1007/BF00581674
[Investigations on the mechanism of the activity of urea upon the epidermis (author's transl)].
W. Wohlrab (1976)
Effects of topical petrolatum and salicylic acid upon skin photoreaction to UVA.
B. Birgin (2005)
[Salicylate poisoning by percutaneous resorption].
E. Diem (1973)
Modulation der Wirkstoffpenetration in die Haut
J. Kalbitz (1996)
Hydratisierender und die Steroid-penetration modifizierender Effekt von Harnstoff und Glycerin in Abhängigkeit von der verwendeten Grundlage
J. Fluhr (1998)
10.1007/BF00562229
Die wirkung der salicylsäure auf die proliferationskinetik psoriatischer epidermiszellen
H. Pullmann (2004)
10.1001/ARCHDERM.1974.01630010038008
Percutaneous penetration of hydrocortisone with urea.
R. Feldmann (1974)



This paper is referenced by
10.4172/2155-9554.1000243
Corticosteroid Cream Once Daily plus an Emollient Cream in comparison with Corticosteroid Cream Twice Daily in Plaque Psoriasis: An Intra- Patient, Randomized Assessor-Blinded, Ultrasound Evaluation Study
Francesco Lacarrubba (2014)
What evidence is there for moisturisers ?
(2011)
10.2147/PHMT.S75834
Treating pediatric plaque psoriasis: challenges and solutions
J. Thomas (2016)
10.1016/B978-0-323-42868-2.00011-5
Skin autoimmune disorders: lipid biopolymers and colloidal delivery systems for topical delivery
D. Singh (2016)
10.1186/1477-3155-9-44
Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments
D. S. Bernardi (2011)
10.1016/S1578-2190(10)70662-4
[Climatic change and skin: diagnostic and therapeutic challenges].
M. Llamas-Velasco (2010)
10.5937/mp71-22175
Examination of the influence of inorganic salts on the extraction of salicylic acid from aqueous solutions
Kristina Pešić (2020)
10.1111/j.1600-0625.2009.00903.x
Emollient for maintenance therapy after topical corticotherapy in mild psoriasis
S. Seité (2009)
The Role ofthe Specialty Pharmacist in Optimizing the Quality of Care for Patients with Psoriasis and Psoriatic Arthritis
C. MacDonnell (2015)
10.1208/s12249-011-9661-7
Microparticulate Based Topical Delivery System of Clobetasol Propionate
Ulya Badilli (2011)
10.1684/ejd.2014.2294
Recommendations for adjunctive basic skin care in patients with psoriasis
T. Luger (2014)
The Role of the Specialty Pharmacist in Optimizing the Quality of Care for Patients with Psoriasis and Psoriatic Arthritis
C. MacDonnell (2015)
10.1111/jdv.14128
A randomized, double‐blind, placebo‐controlled, dose‐escalation first‐in‐man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis
S. H. Omland (2017)
10.1016/J.ANNDER.2017.09.136
Détection et impact d’une séropositivité VIH chez les patients atteints de psoriasis. Une enquête de pratiques
M. Guignant (2017)
Towards a comprehensive resource for elucidating the pathogenesis of inherited keratodermas
M. Zamiri (2010)
Diagnostic and therapeutic innovations of phototherapy in psoriasis and (pre)malignancies of the skin
M. M. Kleinpenning (2007)
Création d'un site internet de conseils en dermocosmétologie du visage, chez l'adulte, destiné aux pharmaciens d'officine
C. Charles (2012)
10.12968/NPRE.2013.11.6.276
Prescribing emollients for dry skin conditions
Rebecca Penzer (2013)
10.1177/247553031420a00106
A Guide to the Ingredients of Over-the-Counter Moisturizers for Psoriasis
L. Chularojanamontri (2014)
10.1002/14651858.CD005028.pub3
Topical treatments for chronic plaque psoriasis.
A. Mason (2013)
10.15761/GOD.1000196
Palmoplantar Psoriasis: a review of topical therapies
L. Li (2016)
10.2217/EBO.11.27
Current treatment options in psoriasis: topical agents
Kristine B. Zitelli (2011)
10.12968/BJHC.2014.20.7.315
Prescribing emollients for dry skin conditions
Rebecca Penzer (2014)
10.2147/PTT.S130295
Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis
Ulrich R. Hengge (2017)
NHG-Standaard Psoriasis (derde herziening)
P. Peet (2014)
10.1007/s13555-016-0119-4
Patient Preferences for Topical Psoriasis Treatments are Diverse and Difficult to Predict
L. Iversen (2016)
10.1007/s13555-015-0068-3
Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review
A. Jacobi (2015)
10.4103/2229-5178.209622
Topical Therapies in Psoriasis
R. Torsekar (2017)
10.18231/J.IJCED.2019.030
Efficacy of various topical agents in chronic plaque type psoriasis
Sugandh Bhattar (2019)
10.11606/D.60.2011.TDE-11042011-140431
Desenvolvimento de nanoemulsão de óleo de arroz como adjuvante no tratamento de dermatite atópica e psoríase
D. S. Bernardi (2011)
10.1111/jdv.16691
Tolerance and efficacy of a new celastrol-containing balm as adjunct care in psoriasis.
M. Thouvenin (2020)
10.1111/bjd.15543
A randomized controlled trial to evaluate the effect of a new skincare regimen on skin barrier function in those with podoconiosis in Ethiopia
J. Brooks (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar